retatrutide side effects clinical trials 2025 Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 New Obesity Drug Helped People

If you have time for a relaxing drip session and want a slow, steady infusion, traditional IV therapy is an excellent option

Sleep improvements are typically the first thing patients at our Miami clinic report, often beginning within the first few nights of the cycle

The commercial features a polar bear discovering his preference for Pepsi Zero Sugar over Coke Zero Sugar in a blind taste test, set to Queens I Want to Break Free. The ad arrives as demand for zero-sugar sodas accelerates among health-conscious consumers, with Pepsi Zero Sugar posting 30.8% growth in 2025, nearly double the zero-sugar cola category

Advances in stem cell therapies for rotator cuff injuries

Participants who maintained semaglutide therapy after initial weight loss sustained their improvements over an additional 48 weeks, while those switched to placebo experienced significant weight regain